Current Issue

Application of Quality Risk Management to Process Validation

Robert Dream, Managing Director, HDR Company LLC

A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization

Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...

Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...

Ping Wang, Director, Johnson & Johnson

Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics

Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...

Amsphere A3

JSR Life Sciences



Headline News

Pfizer’s 25-valent pneumococcal vaccine shows robust immune responses in Phase II infant study


FDA approves subcutaneous SKYRIZI induction regimen for Crohn’s disease


FDA expands TALZENNA plus XTANDI approval to earlier metastatic prostate cancer setting


Read All Headlines

Upcoming Webinars

View All Upcoming Webinars

Past Webinars

The Business Benefits of PAT in Continuous Drug Product Manufacturing

Presented by Steve Hammond, Independent Consultant at Steve Hammond Consulting
22nd September 2021


Points to consider when defining a microbial control strategy for individualized ATMPs

Presented by Friedrich von Wintzingerode, PhD, QC Lead iNeST Project (individualized Neoantigen Specific Therapy)
05th April 2023


Latest Analytical Techniques in Extractable and Leachables

Presented by Dr. Tom van Wijk, Abbott Healthcare Products BV, Weesp, Principal Scientist, Analytical Science and Technology Team lead Pharmaceutical analysis
20th May 2021


View All Past Webinars

Featured Companies

 

View All Companies

© 2026 biopharma-asia.com. All rights reserved. Privacy Policy

Biopharma Asia